Trials / Unknown
UnknownNCT03889964
Exercise Capacity in COPD
Reduced Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease -Relevance of Cardiovascular Comorbidities
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Klinik für Kardiologie, Pneumologie und Angiologie · Academic / Other
- Sex
- All
- Age
- 40 Years – 40 Years
- Healthy volunteers
- —
Summary
In this study, cardiopulmonary exercise will be assessed to characterize the relevance of severity of COPD and coexisting cardiovascular comorbidities for exercise capacity.
Detailed description
In patients with chronic obstructive pulmonary disease (COPD) the interpretation of dyspnoea also needs to consider coexisting cardiovascular disease. Cardiopulmonary exercise testing (CPET) is used to characterize pulmonary and cardiac function and limitations during exercise. The investigators hypothesise that cardiopulmonary exercise is reduced in COPD patients with coexisting cardiovascular disease as well as in more symptomatic patients and in patients with frequent exacerbations. For this purpose, 100 patients with with stable COPD are characterized by clinical characteristics, laboratory tests, lung function, electrocardiography, echocardiography and cardiopulmonary exercise testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Measurement of lung function, electrocardiography, echocardiography and cardiopulmonary exercise testing | Measurement of lung function, electrocardiography, echocardiography and cardiopulmonary exercise testing |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2019-03-26
- Last updated
- 2020-02-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03889964. Inclusion in this directory is not an endorsement.